Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
123.85B
Market cap123.85B
Price-Earnings ratio
26.45
Price-Earnings ratio26.45
Dividend yield
2.94%
Dividend yield2.94%
Average volume
6.25M
Average volume6.25M
High today
$96.71
High today$96.71
Low today
$94.64
Low today$94.64
Open price
$95.00
Open price$95.00
Volume
5.03M
Volume5.03M
52 Week high
$99.37
52 Week high$99.37
52 Week low
$79.29
52 Week low$79.29

Stock Snapshot

The current Medtronic(MDT) stock price is $96.30, with a market capitalization of 123.85B. The stock trades at a price-to-earnings (P/E) ratio of 26.45 and offers a dividend yield of 2.9%.

As of 2025-11-13, Medtronic(MDT) stock has fluctuated between $94.64 and $96.71. The current price stands at $96.30, placing the stock +1.8% above today's low and -0.4% off the high.

The Medtronic(MDT)'s current trading volume is 5.03M, compared to an average daily volume of 6.25M.

In the last year, Medtronic(MDT) shares hit a 52-week high of $99.37 and a 52-week low of $79.29.

In the last year, Medtronic(MDT) shares hit a 52-week high of $99.37 and a 52-week low of $79.29.

MDT News

TipRanks 14h
Medtronic price target raised to $100 from $90 at JPMorgan

JPMorgan raised the firm’s price target on Medtronic (MDT) to $100 from $90 and keeps a Neutral rating on the shares ahead of the fiscal Q2 report. Meet Your E...

Simply Wall St 24h
A Look at Medtronic’s Valuation Following Minze Health Partnership and Expansion of Digital Bladder Monitoring Solutions

Medtronic has signed a three-year deal with Minze Health to commercialize the Minze Diary Pod across Europe, the Middle East and Africa. This move strengthens M...

A Look at Medtronic’s Valuation Following Minze Health Partnership and Expansion of Digital Bladder Monitoring Solutions
Nasdaq 2d
MDT Q2 Earnings Preview: Cardiovascular Unit Likely to Boost Growth

Medtronic MDT is set to release second-quarter fiscal 2026 results on Nov. 18, before the market opens. The MedTech giant posted earnings per share (EPS) of $1...

MDT Q2 Earnings Preview: Cardiovascular Unit Likely to Boost Growth

Analyst ratings

55%

of 33 ratings
Buy
54.5%
Hold
42.4%
Sell
3%

More MDT News

Benzinga 2d
Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact

Medical devices giant Medtronic Plc (NYSE:MDT) is scheduled to report its second-quarter fiscal year 2026 results on Tuesday, November 18. According to data fr...

Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact
The Motley Fool 2d
Intuitive Surgical Is the Robotic-Assisted Surgery Leader, but Medtronic Is Making Moves. Here's What Investors Need to Know.

Medtronic has its own surgical robot and it is working to become a more profitable business. There is a lot to like about Intuitive Surgical (ISRG +0.13%) and...

Intuitive Surgical Is the Robotic-Assisted Surgery Leader, but Medtronic Is Making Moves. Here's What Investors Need to Know.
Simply Wall St 6d
Did Medtronic’s Positive Renal Denervation Results Just Shift Its Hypertension Device Narrative?

In late October 2025, Medtronic announced new three-year clinical results at the TCT conference showing its Symplicity Spyral renal denervation system significa...

Did Medtronic’s Positive Renal Denervation Results Just Shift Its Hypertension Device Narrative?

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.